Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Brief description of study

The purpose of this research study is to learn more about the effects of the study drug called MW189 in people who have bleeding in the brain, including intracerebral hemorrhage or ICH. Some participants in this study will take MW189 and some participants will take placebo (an inactive material that does not contain any active drug). Your participation in this study will last about 6 months and include approximately 7 study visits to the study center and at least 1 phone call.

PLEASE NOTE – enrollment in this study is limited to current Emergency Department and ICU patients within 24 hours of symptom onset only.


Clinical Study Identifier: s22-00126
ClinicalTrials.gov Identifier: NCT05020535
Principal Investigator: Aaron S Lord.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.